Moderna, Inc. (MRNA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Moderna, Inc. presented at the Bernstein 42nd Annual Strategic Decisions Conference on May 28, 2026. CEO Stéphane Bancel discussed the company's evolution and future prospects, emphasizing the importance of AI in drug discovery. The conference provided insights into Moderna's strategic direction and innovations.
- ▪Moderna's CEO Stéphane Bancel participated in the Bernstein conference.
- ▪The discussion focused on the company's history and future plans.
- ▪AI's role in drug discovery was highlighted as a key topic for investors.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4909809-moderna-inc-mrna-presents-at-bernstein-42nd-annual-strategic-decisions-conference-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
